Medico Remedies Hits 52-Week Low Amid Mixed Financial Performance and Stakeholder Concerns

Medico Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has seen significant activity today, hitting a new 52-week low of Rs. 35. The stock has underperformed its sector by 0.49% and has experienced a consecutive decline over the past two days, resulting in a total drop of 1.4%. Currently, Medico Remedies is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging market position.
In terms of financial health, the company demonstrates a strong ability to service its debt, with a low Debt to EBITDA ratio of 0.94 times. Operating profit has shown robust growth, increasing at an annual rate of 32.76%. Recent financial results indicate a PAT of Rs. 6.16 crore, reflecting a growth of 31.62%, while net sales for the quarter reached Rs. 38.25 crore, up by 24.19%.

Despite a modest one-year performance of 0.08%, Medico Remedies has seen its profits rise by 20.7%. However, a decrease in promoter stake by 1.2% over the previous quarter, now at 62.59%, may suggest waning confidence in the company's future prospects.